145 related articles for article (PubMed ID: 36584732)
21. 25 years of the WHO essential medicines lists: progress and challenges.
Laing R; Waning B; Gray A; Ford N; 't Hoen E
Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
[TBL] [Abstract][Full Text] [Related]
22. Essential Medicines List Implementation Dynamics: A Case Study Using Brazilian Federal Medicines Expenditures.
Magarinos-Torres R; Lynd LD; Luz TCB; Marques PEPC; Osorio-de-Castro CGS
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):181-188. PubMed ID: 28371342
[TBL] [Abstract][Full Text] [Related]
23. Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
Roitberg F; Amaral T; Cherny NI; Giuliani R; Latino NJ; Galotti M; Bricalli G; Curigliano G; Pentheroudakis G; Trapani D
ESMO Open; 2023 Oct; 8(5):101617. PubMed ID: 37672862
[TBL] [Abstract][Full Text] [Related]
24. Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders.
Jarvis JD; Murphy A; Perel P; Persaud N
CMAJ; 2019 Oct; 191(40):E1093-E1099. PubMed ID: 31591095
[TBL] [Abstract][Full Text] [Related]
25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
26. The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
Mori AT; Kaale EA; Ngalesoni F; Norheim OF; Robberstad B
PLoS One; 2014; 9(1):e84824. PubMed ID: 24416293
[TBL] [Abstract][Full Text] [Related]
27. Advancing the WHO-INTEGRATE Framework as a Tool for Evidence-Informed, Deliberative Decision-Making Processes: Exploring the Views of Developers and Users of WHO Guidelines.
Stratil JM; Paudel D; Setty KE; Menezes de Rezende CE; Monroe AA; Osuret J; Scheel IB; Wildner M; Rehfuess EA
Int J Health Policy Manag; 2022 May; 11(5):629-641. PubMed ID: 33131223
[TBL] [Abstract][Full Text] [Related]
28. Essential medicines are more available than other medicines around the globe.
Bazargani YT; Ewen M; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
PLoS One; 2014; 9(2):e87576. PubMed ID: 24533058
[TBL] [Abstract][Full Text] [Related]
29. Challenges in updating national guidelines and essential medicines lists in Sub-Saharan African countries to include WHO-recommended postpartum hemorrhage medicines.
Ng'ang'a J; Chitimbe T; Mburu R; Rushwan S; Ntirushwa D; Chinery L; Gülmezoglu AM
Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):11-13. PubMed ID: 35762803
[TBL] [Abstract][Full Text] [Related]
30. A structured methodology for essential medicines lists and health emergency stockpiles: Experience with the Emergency Medicines Buffer Stock in the United Kingdom.
Angelis A; Montibeller G; Kanavos P
Soc Sci Med; 2023 Nov; 337():116236. PubMed ID: 37857240
[TBL] [Abstract][Full Text] [Related]
31. Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.
Jeličić Kadić A; Žanić M; Škaričić N; Marušić A
PLoS One; 2014; 9(10):e111474. PubMed ID: 25337860
[TBL] [Abstract][Full Text] [Related]
32. Essential medicines lists for children of WHO, India, South Africa, and EML of China: A comparative study.
Liu D; Cheng J; Zhang LL; Li YP; Zeng LN; Zhang C; Gui G
J Evid Based Med; 2017 Nov; 10(4):271-280. PubMed ID: 28276634
[TBL] [Abstract][Full Text] [Related]
33. Essential Medicines in a High Income Country: Essential to Whom?
Duong M; Moles RJ; Chaar B; Chen TF;
PLoS One; 2015; 10(12):e0143654. PubMed ID: 26650544
[TBL] [Abstract][Full Text] [Related]
34. Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries.
Bruyn E; Nguyen L; Schutte AE; Murphy A; Perel P; Webster R
Glob Heart; 2022; 17(1):6. PubMed ID: 35174047
[TBL] [Abstract][Full Text] [Related]
35. OS032. Pharmacotherapy for pre-eclampsia in low and middle income countries: An analysis of essential medicines lists (EMLS).
Lalani S; Firoz T; Magee LA; Lowe R; Sawchuck D; Payne B; Gordon R; Vidler M; von Dadelszen P
Pregnancy Hypertens; 2012 Jul; 2(3):193-4. PubMed ID: 26105246
[TBL] [Abstract][Full Text] [Related]
36. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
[TBL] [Abstract][Full Text] [Related]
37. Essential medicines for emergency care in Africa.
Broccoli MC; Pigoga JL; Nyirenda M; Wallis LA; Calvello Hynes EJ
Afr J Emerg Med; 2018 Sep; 8(3):110-117. PubMed ID: 30456159
[TBL] [Abstract][Full Text] [Related]
38. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
39. Medicines for cancers in children: The WHO model for selection of essential medicines.
Robertson J; Magrini N; Barr R; Forte G; Ondari C
Pediatr Blood Cancer; 2015 Oct; 62(10):1689-93. PubMed ID: 25929524
[TBL] [Abstract][Full Text] [Related]
40. Access to WHO Essential Medicines for Childhood Cancer Care in Trinidad and Tobago: A Health System Analysis of Barriers and Enablers.
Tang B; Bodkyn C; Gupta S; Denburg A
JCO Glob Oncol; 2020 Feb; 6():67-79. PubMed ID: 32031441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
